These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 6821401)

  • 1. In vivo release of lymphokines in inbred murine strains.
    Neta R; Salvin SB
    Lymphokine Res; 1982; 1(2):29-35. PubMed ID: 6821401
    [No Abstract]   [Full Text] [Related]  

  • 2. Antigen-specific production of lymphokines is influenced by the MHC/antigen complex presented to T lymphocytes.
    Dieli F; Salerno A
    Transplant Proc; 1993 Dec; 25(6):3297-8. PubMed ID: 8266549
    [No Abstract]   [Full Text] [Related]  

  • 3. Mechanisms in the in vivo release of lymphokines. 1. Comparative kinetics in the release of six lymphokines in inbred strains of mice.
    Neta R; Salvin SB; Sabaawi M
    Cell Immunol; 1981 Nov; 64(2):203-19. PubMed ID: 6171354
    [No Abstract]   [Full Text] [Related]  

  • 4. Discussion paper: a tumor-inhibiting lymphokine from tuberculous mice.
    Salvin SB; Youngner JS; Nishio J; Neta R
    Ann N Y Acad Sci; 1976; 276():369-72. PubMed ID: 800323
    [No Abstract]   [Full Text] [Related]  

  • 5. Infection of mice with Mycobacterium bovis-BCG induces both Th1 and Th2 immune responses in the absence of interferon-gamma signalling.
    Erb KJ; Kirman J; Delahunt B; Moll H; Le Gros G
    Eur Cytokine Netw; 1999 Jun; 10(2):147-54. PubMed ID: 10400820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of species specificity of a skin-reactive factor released from sensitized guinea pig spleen cells.
    Yoshida T; Nagai R; Hashimoto T
    Lab Invest; 1973 Sep; 29(3):329-35. PubMed ID: 4598145
    [No Abstract]   [Full Text] [Related]  

  • 7. [Genetic control of production of a lymphokine inhibiting macrophage migration in mice].
    Petrov RV; Koval'chuk LV; Sokolova EV; Burtseva LV
    Genetika; 1980; 16(10):1825-33. PubMed ID: 7007159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance and susceptibility to infection in inbred murine strains. II. Variations in the effect of treatment with thymosin fraction 5 on the release of lymphokines in vivo.
    Neta R; Salvin SB
    Cell Immunol; 1983 Jan; 75(1):173-80. PubMed ID: 6402312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-specific release of migration inhibitory factor by senescent immune lung cells in aged guinea pigs.
    Ganguly R
    Adv Exp Med Biol; 1987; 216B():1417-20. PubMed ID: 3321937
    [No Abstract]   [Full Text] [Related]  

  • 10. T-helper 1-like subset selection in Mycobacterium bovis bacillus Calmette-Guérin-infected resistant and susceptible mice.
    Kramnik I; Radzioch D; Skamene E
    Immunology; 1994 Apr; 81(4):618-25. PubMed ID: 8039813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms in the in vivo release of lymphokines: relationship of high and low responsiveness to other parameters of the immune response.
    Neta R; Salvin SB
    Infect Immun; 1981 Oct; 34(1):160-5. PubMed ID: 6170585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuation of MHC class II expression in macrophages infected with Mycobacterium bovis bacillus Calmette-Guérin involves class II transactivator and depends on the Nramp1 gene.
    Wojciechowski W; DeSanctis J; Skamene E; Radzioch D
    J Immunol; 1999 Sep; 163(5):2688-96. PubMed ID: 10453010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Environmental strains of Mycobacterium avium interfere with immune responses associated with Mycobacterium bovis BCG vaccination.
    Young SL; Slobbe L; Wilson R; Buddle BM; de Lisle GW; Buchan GS
    Infect Immun; 2007 Jun; 75(6):2833-40. PubMed ID: 17371857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variation among mouse strains in responsiveness to migration inhibitory factor.
    Tagliabue A; Herberman RB; McCoy JL
    Cell Immunol; 1979 Jul; 45(2):464-8. PubMed ID: 380823
    [No Abstract]   [Full Text] [Related]  

  • 15. Aerosol infection of mice with recombinant BCG secreting murine IFN-gamma partially reconstitutes local protective immunity.
    Moreira AL; Tsenova L; Murray PJ; Freeman S; Bergtold A; Chiriboga L; Kaplan G
    Microb Pathog; 2000 Sep; 29(3):175-85. PubMed ID: 10968949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Murine IL-2 secreting recombinant Bacillus Calmette-Guerin augments macrophage-mediated cytotoxicity against murine bladder cancer MBT-2.
    Yamada H; Matsumoto S; Matsumoto T; Yamada T; Yamashita U
    J Urol; 2000 Aug; 164(2):526-31. PubMed ID: 10893638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferons and lymphokines.
    Neta R; Salvin SB
    Tex Rep Biol Med; 1981-1982; 41():435-42. PubMed ID: 6820576
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of IL-12 in macrophage activation during intracellular infection: IL-12 and mycobacteria synergistically release TNF-alpha and nitric oxide from macrophages via IFN-gamma induction.
    Xing Z; Zganiacz A; Santosuosso M
    J Leukoc Biol; 2000 Dec; 68(6):897-902. PubMed ID: 11129658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphoid sources of murine migration inhibition factor.
    Adelman NE; Ksiazek J; Yoshida T; Cohen S
    J Immunol; 1980 Feb; 124(2):825-30. PubMed ID: 6985938
    [No Abstract]   [Full Text] [Related]  

  • 20. Genetic aspects of macrophage activation for tumor cytotoxicity.
    Boraschi D
    Adv Exp Med Biol; 1982; 141():119-28. PubMed ID: 7046393
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.